Leticia Ramírez-Lugo

Leticia Ramírez-Lugo

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2016 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
LRLeticia Ramírez-Lugo
Leticia Ramírez-Lugo
APAna Peñas-Rincón
Ana Peñas-Rincón
SÁSandybel Ángeles-Durán
Sandybel Ángeles-Durán
FSFrancisco Sotres-Bayon
Francisco Sotres-Bayon
The ability to select an appropriate behavioral response guided by previous emotional experiences is critical for survival. Although much is known about brain mechanisms underlying emotional associations, little is known about how these associations guide behavior when several choices are available. To address this, we performed local pharmacological inactivations of several cortical regions before retrieval of an aversive memory in choice-based versus no-choice-based conditioned taste aversion (CTA) tasks in rats. Interestingly, we found that inactivation of the orbitofrontal cortex (OFC), but not the dorsal or ventral medial prefrontal cortices, blocked retrieval of choice CTA. However, OFC inactivation left retrieval of no-choice CTA intact, suggesting its role in guiding choice, but not in retrieval of CTA memory. Consistently, OFC activity increased in the choice condition compared with no-choice, as measured with c-Fos immunolabeling. Notably, OFC inactivation did not affect choice behavior when it was guided by innate taste aversion. Consistent with an anterior insular cortex (AIC) involvement in storing taste memories, we found that AIC inactivation impaired retrieval of both choice and no-choice CTA. Therefore, this study provides evidence for OFC's role in guiding choice behavior and shows that this is dissociable from AIC-dependent taste aversion memory. Together, our results suggest that OFC is required and recruited to guide choice selection between options of taste associations relayed from AIC.SIGNIFICANCE STATEMENTSurvival and mental health depend on being able to choose stimuli not associated with danger. This is particularly important when danger is associated with stimuli that we ingest. Although much is known about the brain mechanisms that underlie associations with dangerous taste stimuli, very little is known about how these stored emotional associations guide behavior when it involves choice. By combining pharmacological and immunohistochemistry tools with taste-guided tasks, our study provides evidence for the key role of orbitofrontal cortex activity in choice behavior and shows that this is dissociable from the adjacent insular cortex-dependent taste aversion memory. Understanding the brain mechanisms that underlie the impact that emotional associations have on survival choice behaviors may lead to better treatments for mental disorders characterized by emotional decision-making deficits.

26 August 2009 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
LRLeticia Ramírez-Lugo
Leticia Ramírez-Lugo
MJMorten S. Jensen
Morten S. Jensen
ASAndreas Søderman
Andreas Søderman
MWMark J. West
Mark J. West
Age-related changes in taste memory were evaluated in APPswe/PS1dE9 transgenic (Tg) mice and age-matched wild type littermate controls (Wt). These Tg mice produce increasing amounts of amyloid-β in the brain with age, develop significant amounts of p

7 September 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Wendy Herrera-MoralesWendy Herrera-Morales
Wendy Herrera-Morales
JRJulián Reyes-López
Julián Reyes-López
KCKaren Nicte-Ha Tuz Castellanos
Karen Nicte-Ha Tuz Castellanos
DODesiree Ortegón-Abud
Desiree Ortegón-Abud
LRLeticia Ramírez-Lugo
Leticia Ramírez-Lugo
Luis Núñez-JaramilloLuis Núñez-Jaramillo
Luis Núñez-Jaramillo
ADHD is a neurodevelopmental disorder appearing in childhood but remaining in many cases in adults. There are both pharmacological and non-pharmacological approaches to treating ADHD, but they do not have the same efficacy in all subjects. Better knowledge of the neurophysiological basis of this disorder will allow for the design of more effective treatments. Studies performing qEEG analysis in children suggest the existence of subgroups of ADHD patients with different neurophysiological traits. There are fewer studies in adults, who might have undergone plastic changes allowing them to cope with ADHD symptoms along with brain maturation. Herein, we study cognitive performance and the theta/beta ratio in young adults with ADHD symptoms. We found that subjects with ADHD symptoms and low working memory performance (n = 30) present higher theta/beta ratios than controls (n = 40) at O2 and T6 in the eyes-closed condition, as well as a tendency toward a higher theta/beta ratio at O1 and Cz. Subjects with ADHD and high working memory performance (n = 50) do not differ from the controls in their theta/beta ratios at any derivation. Our results suggest that neuropsychological profiling could be useful for patient subgrouping. Further research will allow for the distinction of neuropsychological profiles and their neurophysiological correlates, leading to a better classification of ADHD subtypes, thus improving treatment selection.

1 January 2019 in Revista De Neurologia
Verified
Journal Article
Closed access
Wendy Herrera-MoralesWendy Herrera-Morales
Wendy Herrera-Morales
LRLeticia Ramírez-Lugo
Leticia Ramírez-Lugo
ESEfraín Santiago-Rodríguez
Efraín Santiago-Rodríguez
JRJulián Reyes-López
Julián Reyes-López
Luis Núñez-JaramilloLuis Núñez-Jaramillo
Luis Núñez-Jaramillo

1 June 2022 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Wendy Herrera-MoralesWendy Herrera-Morales
Wendy Herrera-Morales
LRLeticia Ramírez-Lugo
Leticia Ramírez-Lugo
RCRoger Cauich-Kumul
Roger Cauich-Kumul
EMEric Murillo-Rodríguez
Eric Murillo-Rodríguez
Luis Núñez-JaramilloLuis Núñez-Jaramillo
Luis Núñez-Jaramillo
Attention-deficit hyperactivity disorder is a neurodevelopmental disorder diagnosed primarily in children, although it is also present in adults. Patients present inattention, impulsivity, and hyperactivity symptoms that create difficulties in their daily lives. Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms. Although generally effective and safe, pharmacological treatments have different effects among patients, including lack of response and adverse reactions. The reasons for these differences are not fully understood, but they may derive from the highly diverse etiology of ADHD. Strategies to guide optimal pharmacological treatment selection on the basis of individual patients’ physiological markers are being developed. In this review, we describe the main pharmacological ADHD treatments used and their main drawbacks. We present alternatives under study that would allow the customization of pharmacological treatments to overcome these drawbacks and achieve more reliable improvement of ADHD symptoms.